Patent · US Active

Methods and compositions for the treatment of gastrointestinal disorders

US8110553B2 · kind B2 · utility

13Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 27, 2010
Grant dateFeb 7, 2012
Priority date
Expiry dateMay 27, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/245
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.